Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST
HAMPTON, N.J., Nov. 27, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc.
(Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief
Executive Officer, and Tom Davis, M.D., Senior Vice President and Chief
Medical Officer are scheduled to present at the Deutsche Bank 2013 BioFEST on
Monday, December 2, 2013 at 9:35 am ET at the Four Seasons Hotel in Boston,
A live webcast of the presentation will be available online on the "Events &
Presentations" page of the "Investors & Media" section of the Celldex website.
A replay of the presentation will be available for 30 days following the
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is built from a
proprietary portfolio of antibodies and immunomodulators used alone and in
strategic combinations to create novel, disease-specific therapies that
induce, enhance or suppress the body's immune response. Visit www.celldex.com.
CONTACT: Sarah Cavanaugh
Vice President of Investor Relations &
Celldex Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.